Gruss Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Gruss Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-156,383	Closed	-$1.44M	–	54
2016 Q1	$1.44M	Hold	156,383	–	–	0.05%	42
2015 Q4	$1.97M	Hold	156,383	–	–	0.06%	72
2015 Q3	$1.89M	Hold	156,383	–	–	0.06%	74
2015 Q2	$2.72M	Hold	156,383	–	–	0.1%	58
2015 Q1	$2.27M	Buy	156,383 +2,883	+2%	+$31.5K	0.09%	59
2014 Q4	$1.29M	Buy	153,500 +17,200	+13%	+$157K	0.04%	82
2014 Q3	$1.51M	Buy	136,300 +82,975	+156%	+$1.05M	0.07%	62
2014 Q2	$976K	Buy	+53,325	New	+$694K	0.05%	65

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

DVC

Deer VI & Co Larchmont, New York $2.23M AUM 9.32% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Gruss Capital Management's AVEO Position: Q2 2016 in Review

Gruss Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2016, closing a stake of 156,383 shares — an estimated $1.44M sold.

Gruss Capital Management first reported a position in AVEO in Q2 2014 and held it in 8 quarters. The position peaked at $2.72M in Q2 2015. 48 funds tracked by Wall St. Rank hold AVEO as of Q2 2016.

Gruss Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Gruss Capital Management sold 156,383 AVEO Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1.44M.
Gruss Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2014 and held it in 8 quarters.
Gruss Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $2.72M in Q2 2015.
48 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2016.

Based on Gruss Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.